DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

42 hedge funds and large institutions have $349M invested in Dicerna Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$73.5M
2
+$68.6M
3
+$68.6M
4
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$42.8M
5
A
Abingworth
United Kingdom
+$33.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$557K
27
$536K
28
$371K
29
$356K
30
$323K
31
$322K
32
$278K
33
$256K
34
$236K
35
$181K
36
$153K
37
$141K
38
$101K
39
$99K
40
$42K
41
$3K
42
$3K
1
2